Lucid, operating under the brand name Caliber Imaging & Diagnostics (Caliber I.D.), has entered into a strategic advisory agreement with investment bank H.C. Wainwright & Co., LLC to assist in its growth and business development. Caliber I.D. provides non-invasive optical biopsies of skin and is also the manufacturer of the VivaScope® confocal imaging systems.
Per the agreement, H.C. Wainwright will advise Caliber I.D. in the identification, origination, and development of potential strategic partnerships, in addition to helping the company execute M&A transactions and raise capital.
H.C. Wainwright will also assist Caliber I.D. with new product development, identifying and generating additional distribution channels, and calculating collaboration efforts to efficiently promote Caliber I.D.’s business throughout the market.
Caliber I.D.’s current integrated platform of VivaScope® products includes non-invasive cellular imaging systems used to diagnose skin disease such as basal cell carcinoma, melanoma, and inflammatory disorders. The technology provides the diagnostic capability in real time with an optical biopsy, providing a non-invasive alternative to traditional or surgical biopsy.
For more information, visit www.caliberid.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment